Literature DB >> 12908994

Break-even analysis revisited: the need to adjust for profitability, the collection rate and autonomous income.

R W Broyles1, L Narine, A Khaliq.   

Abstract

This paper modifies traditional break-even analysis and develops a model that reflects the influence of variation in payer mix, the collection rate, profitability and autonomous income on the desired volume alternative. The augmented model indicates that a failure to adjust for uncollectibles and the net surplus results in a systematic understatement of the desired volume alternative. Conversely, a failure to adjust for autonomous income derived from the operation of cafeterias, gift shops or an organization's investment in marketable securities produces an overstatement of the desired volume. In addition, this paper uses Microsoft Excel to develop a spreadsheet that constructs a pro forma income statement, expressed in terms of the contribution margin. The spreadsheet also relies on the percentage of sales or revenue approach to prepare a balance sheet from which indicators of fiscal performance are calculated. Hence, the analysis enables the organization to perform a sensitivity analysis of potential changes in the desired volume, the operating margin, the current ratio, the debt: equity ratio and the amount of cash derived from operations that are associated with expected variation in payer mix, the collection rate, grouped by payer, the net surplus and autonomous income.

Mesh:

Year:  2003        PMID: 12908994     DOI: 10.1258/095148403322167951

Source DB:  PubMed          Journal:  Health Serv Manage Res        ISSN: 0951-4848


  2 in total

1.  Clinical laboratory as an economic model for business performance analysis.

Authors:  Vikica Buljanović; Hrvoje Patajac; Mladen Petrovecki
Journal:  Croat Med J       Date:  2011-08-15       Impact factor: 1.351

2.  Profit and loss analysis for an intensive care unit (ICU) in Japan: a tool for strategic management.

Authors:  Pengyu Cao; Shin-ichi Toyabe; Toshikazu Abe; Kouhei Akazawa
Journal:  BMC Health Serv Res       Date:  2006-01-11       Impact factor: 2.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.